Cancer News and Research

Latest Cancer News and Research

IASLC presents 19th World Conference on Lung Cancer in Toronto

The International Association for the Study of Lung Cancer presents the IASLC 19th World Conference on Lung Cancer on September 23-26, 2018, in Toronto, Canada.

23 Aug 2018

Qlu Health launches in the UK

A new genetic health testing company that focuses on preventing life altering medical conditions before they are apparent rather than reacting to them has launched in the UK. Qlu Health offers cancer, cardiac, nutrition and gut testing.

23 Aug 2018

Study finds new way to target escalating rates of obesity

A novel drug is being touted as a major step forward in the battle against Australia’s escalating rates of obesity and associated metabolic diseases.

23 Aug 2018

A late-life surprise: Taking care of frail, aging parents

"This won't go on for very long," Sharon Hall said to herself when she invited her elderly mother, who'd suffered several small strokes, to live with her.

23 Aug 2018

Men who consume alcohol during adolescence are more likely to have prostate cancer

Compared with non-drinkers, men who consumed at least seven drinks per week during adolescence had three times the odds of being diagnosed with clinically significant prostate cancer.

23 Aug 2018

Nutrition experts describe and evaluate latest version of the Healthy Eating Index

Dietary risk factors are among the key contributors to mortality and morbidity in the United States and globally, and there is increasing emphasis on understanding the influence of total diet quality and overall dietary patterns rather than single aspects of what we eat and drink.

23 Aug 2018

Eisai: EC approves marketing of LENVIMA as first-line treatment for hepatocellular carcinoma

Eisai Co., Ltd. and Merck & Co., Inc., Kenilworth N.J., U.S.A., known as MSD outside of the United States and Canada, announced today that the European Commission has granted a marketing authorization for the oral receptor tyrosine kinase inhibitor LENVIMA (lenvatinib mesylate) as a single agent for the first-line treatment of adult patients with advanced or unresectable hepatocellular carcinoma who have received no prior systemic therapy.

23 Aug 2018

Big tobacco companies still facilitate tobacco smuggling, studies find

Two new studies from the Tobacco Control Research Group at the University of Bath, published in the BMJ journal, Tobacco Control, expose evidence that big tobacco companies are still facilitating tobacco smuggling, while attempting to control a global system designed to prevent it, and funding studies that routinely overestimate levels of tobacco smuggling.

23 Aug 2018

Scientists work towards solving mystery of incurable blood diseases

Scientists may be on the road to solving the mystery of a group of mostly incurable blood diseases called myelodysplastic syndromes, which cause people to have immature, malfunctioning bone marrow cells that fuel a diverse set of health problems and can lead to leukemia.

23 Aug 2018

Researchers describe how RNA polymerase detects UV light damage in DNA

Damage to DNA is a constant threat to cellular life, and so it is constantly monitored and detected by a family of enzymes called RNA polymerases, resulting in subsequent repair to maintain genome integrity.

23 Aug 2018

I-antigen plays major role in glycan-mediated processes, shows study

Two new studies have unveiled how a peculiar molecule impacts how antibody-producing cells develop and function as well as how normal melanocytes progress to melanoma malignancy.

23 Aug 2018

Immunotherapy combination shrinks melanoma that has spread to the brain

Combination immunotherapy shrank melanoma that has spread to the brain in more than half of the patients in a clinical trial reported in the New England Journal of Medicine led by an investigator at The University of Texas MD Anderson Cancer Center.

23 Aug 2018

Penn's Radiation Oncology department provides VR mindfulness experience for patients

As your eyes scan the horizon, the starry nightscape gives way to the first hints of light as the sun peeks above the point where the ocean meets the sky. As the sun rises over the water, you glance to your right and notice a swing hanging from a tree that's lightly rocking in the gentle breeze, a breeze you can hear as it rustles leaves and calmly plays through the wind chimes on the deck of the house nearby.

22 Aug 2018

Advanced sequencing of nasal polyps provides new insights into allergic conditions

Nasal polyps - soft, grape-like outgrowths that can appear in the nasal passages and sinuses - can be chronic and relentless. Although noncancerous, these outgrowths can grow large enough to block the nose and sinuses, leading to discomfort, breathing problems and infections.

22 Aug 2018

Genetic variants impact outcome in dilated cardiomyopathy patients of African ancestry

Genetic testing is a powerful diagnostic tool that is increasingly being used for the diagnosis of dilated cardiomyopathy, a disease in which the heart becomes enlarged, making it difficult to pump blood. Cardiomyopathy affects more than 3.5 million people in the United States.

22 Aug 2018

Engineers create artificial intelligence system to detect tiny specks of tumors

Doctors may soon have help in the fight against cancer thanks to the University of Central Florida's Computer Vision Research Center.

22 Aug 2018

Daily e-cigarette use could double the risk of heart attacks

Use of e-cigarettes every day can nearly double the odds of a heart attack, according to a new analysis of a survey of nearly 70,000 people, led by researchers at UC San Francisco.

22 Aug 2018

Economic burden of breast cancer can continue long after diagnosis

The financial fallout from breast cancer can last years after diagnosis, particularly for those with lymphedema, a common side effect from treatment, causing cumulative and cascading economic consequences for survivors, their families, and society, a study led by Johns Hopkins Bloomberg School of Public Health researchers suggests.

22 Aug 2018

Surgically-removed tumor specimens can help quickly evaluate cancer drug efficacy

Genetic differences can affect the susceptibility of cancer cells to different drugs. In a new Molecular Oncology study, investigators show that surgically-removed breast and prostate tumor specimens can be used to rapidly screen different drugs to see which ones most effectively target an individual's cancer cells.

22 Aug 2018

Experts join hands to fast-track intervention for cancer survivors with pain

A renowned pain scientist at the University of South Australia, Professor Lorimer Moseley, is teaming up with cancer expert Professor Ian Olver to fast-track a long-awaited intervention for cancer survivors struggling with persistent pain.

22 Aug 2018